Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor

NCT06218069 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Sasanlimab
RADIATION: non-ablative radiotherapy
DRUG: [89Zr]Zr-crefmirlimab berdoxam

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]